Citral reduces breast tumor growth by inhibiting the cancer stem cell marker ALDH1A3

Molecular Oncology - Tập 10 - Trang 1485-1496 - 2016
Margaret Lois Thomas1, Roberto de Antueno2, Krysta Mila Coyle1, Mohammad Sultan1, Brianne Marie Cruickshank1, Michael Anthony Giacomantonio1, Carman Anthony Giacomantonio1,3, Roy Duncan2, Paola Marcato1,2
1Department of Pathology, Dalhousie University, Halifax, NS, Canada
2Department of Microbiology & Immunology, Dalhousie University, Halifax, NS, Canada
3Department of Surgery, Dalhousie University, Halifax, NS, Canada

Tóm tắt

Breast cancer stem cells (CSCs) can be identified by increased Aldefluor fluorescence caused by increased expression of aldehyde dehydrogenase 1A3 (ALDH1A3), as well as ALDH1A1 and ALDH2. In addition to being a CSC marker, ALDH1A3 regulates gene expression via retinoic acid (RA) signaling and plays a key role in the progression and chemotherapy resistance of cancer. Therefore, ALDH1A3 represents a druggable anti‐cancer target of interest. Since to date, there are no characterized ALDH1A3 isoform inhibitors, drugs that were previously described as inhibiting the activity of other ALDH isoforms were tested for anti‐ALDH1A3 activity. Twelve drugs (3‐hydroxy‐dl‐kynurenine, benomyl, citral, chloral hydrate, cyanamide, daidzin, DEAB, disulfiram, gossypol, kynurenic acid, molinate, and pargyline) were compared for their efficacy in inducing apoptosis and reducing ALDH1A3, ALDH1A1 and ALDH2‐associated Aldefluor fluorescence in breast cancer cells. Citral was identified as the best inhibitor of ALDH1A3, reducing the Aldefluor fluorescence in breast cancer cell lines and in a patient‐derived tumor xenograft. Nanoparticle encapsulated citral specifically reduced the enhanced tumor growth of MDA‐MB‐231 cells overexpressing ALDH1A3. To determine the potential mechanisms of citral‐mediated tumor growth inhibition, we performed cell proliferation, clonogenic, and gene expression assays. Citral reduced ALDH1A3‐mediated colony formation and expression of ALDH1A3‐inducible genes. In conclusion, citral is an effective ALDH1A3 inhibitor and is able to block ALDH1A3‐mediated breast tumor growth, potentially via blocking its colony forming and gene expression regulation activity. The promise of ALDH1A3 inhibitors as adjuvant therapies for patients with tumors that have a large population of high‐ALDH1A3 CSCs is discussed.

Tài liệu tham khảo

10.1016/j.stemcr.2015.12.006 10.1073/pnas.0530291100 10.1038/nm0797-730 10.18632/oncotarget.3703 10.1111/j.1472-8206.2009.00738.x 10.1158/0008-5472.CAN-08-2741 10.1158/0008-5472.CAN-06-2126 Coyle K.M., 2013, Retinoid signaling in cancer and its promise for therapy, J. Carcinog. Mutagen, 2013 10.1038/nature07733 10.1038/onc.2011.181 10.1016/j.stem.2007.08.014 10.1007/978-1-60761-609-2_3 10.18632/oncotarget.5723 10.3892/ijo.2014.2801 10.1038/modpathol.2011.172 10.1124/pr.111.005538 10.18632/oncotarget.5417 10.1097/JTO.0b013e318257cc6d 10.1038/bjc.2012.442 10.1016/j.stemcr.2013.11.009 10.18632/oncotarget.2166 10.1002/stem.1193 10.1111/j.1530-0277.1993.tb05233.x 10.1073/pnas.1221478110 10.1002/stem.563 10.1016/j.molonc.2014.07.010 10.1016/j.cbi.2011.10.007 10.1021/ac500153a 10.4048/jbc.2015.18.3.225 10.1007/s00432-014-1685-4 10.1158/0008-5472.CAN-13-3456 10.1158/0008-5472.CAN-07-5480 10.1158/1078-0432.CCR-13-3292 10.1038/nrclinonc.2010.196 10.18632/oncotarget.604 10.1021/jf035517j 10.1007/s10585-011-9395-7 10.1186/1479-7364-2-2-138 10.1007/s12032-013-0574-z 10.1038/modpathol.2013.189 10.1097/CMR.0000000000000144 10.1007/s11095-015-1643-0